WestPoint Pharmaceutical: China Investment Corporation and Hangzhou Chuanghe jointly reduce their holdings by 3.23%

West Point Pharmaceuticals announced that Guotou High-Tech Investment Co., Ltd. and Hangzhou Chuanghe Selected Entrepreneurship Investment Partnership collectively reduced their holdings of the company by 2.4675 million shares, accounting for 3.23% of the company's total share capital. Among them, Guotou High-Tech reduced its holdings by 1.8026 million shares through centralized bidding, block trading, and inquiry transfer, accounting for 2.36% of the company's total share capital; Hangzhou Chuanghe reduced its holdings by 664,900 shares through centralized bidding, accounting for 0.87% of the company's total share capital. After this reduction, Guotou High-Tech holds 2.484 million shares of the company, accounting for 3.25% of the total share capital, and Hangzhou Chuanghe holds 677,100 shares, accounting for 0.89% of the total share capital. This reduction will not result in a change in the company's control, nor will it have a significant impact on the company's governance structure and ongoing operations.